000			05986nam a22004455i 4500
999			_c394487 _d394487
001			394487
003			ES-MaUEC
005			20230105141539.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			221124s2022 sz | s |||| 0|eng d
020			_a9783031055324
024	7		_a10.1007/978-3-031-05532-4 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRD539.8 _b2022 EB
245	0	2	_aA Comprehensive Guide to Core Needle Biopsies of the Breast _cedited by Sandra J Shin, Yunn-Yi Chen, Paula S Ginter
250			_a2nd edition 2022
264		1	_aCham _bSpringer International Publishing _c2022
300			_a1 recurso en línea (XVI, 1019 páginas) _b1030 ilustraciones, 999 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
505	0		_aEssential Components of a Successful Breast Core Needle Biopsy Program: Imaging Modalities, Sampling Techniques, Specimen Processing, Radiologic/Pathologic Correlation, and Appropriate Follow-Up -- Pattern-Based Evaluation of Breast Core Needle Biopsies -- Multiples in Core Biopsy Samples -- Inflammatory, Reactive, and Infectious Conditions of the Breast -- Adenosis, Sclerosing Lesions, Microglandular Adenosis, and Mucocele-Like Lesions -- Papillary Tumors and Epithelial and Myoepithelial tumors (Pleomorphic adenoma, Adenomyoepithelioma, Malignant Adenomyoepithelioma) -- Fibroepithelial Lesions -- Columnar Cell Lesions -- Intraductal Proliferations (UDH, ADH, DCIS) -- Invasive Ductal Carcinoma, NST (including microinvasive carcinoma), Tubular Carcinoma, and Cribriform Carcinoma -- Triple-Negative/Basal-Like Breast Carcinomas -- Less Common Triple-Negative Breast Cancers and Salivary Gland-Type Tumors (Carcinoma with Apocrine differentiation, Metaplastic carcinoma, Adenoid Cystic Carcinoma, Secretory Carcinoma, Acinic Cell Carcinoma, Mucoepidermoid carcinoma, Tall Cell Carcinoma with Reversed Polarity) -- Special Histologic Types and Special Morphologic Patterns of Invasive Ductal Carcinoma, NST (Mucinous, Micropapillary, Mucinous Cystadenocarcinoma, Cystic Hypersecretory, Glycogen-Rich Clear Cell, Carcinoma with Osteoclast-Like Giant Cells, Neuroendocrine Neoplasms) -- Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ -- Invasive Lobular Carcinoma -- Benign and Malignant Mesenchymal Tumors -- Vascular Lesions of the Breast -- Breast Tumors in Adolescents/Children and Males -- Lesions of the Nippe -- Lymphoid and Hematopoietic Tumors of the Breast -- Special Clinical Settings: Tumors Arising in Pregnancy, Pregnancy-Like (Pseudolactational) Proliferations, Breast Carcinoma in the Pre-neoadjuvant Chemotherapy Setting, Recurrent Breast Carcinoma, and Inflammatory Breast Carcinoma -- Current Standard Clinical Predictive Markers -- Future Role of Molecular Profiling in Small Breast Samples and Personalized Medicine -- Metastases to the Breast -- Dermatologic Mimickers of Breast Lesions Arising in the Breast Skin, Subcutis, or Axilla.
520			_aBreast cancer remains the leading cause of cancer in women, which makes accurate diagnoses on core needle biopsy (CNB) specimens of vital importance in staging and guiding therapy decisions for patients. The first edition of this multi-authored text written by leaders in the field from major academic medical centers provided a comprehensive guide on diagnostic breast pathology in the core biopsy setting. In addition to in-depth coverage of benign and malignant entities encountered in breast core biopsies, the book provided additional resources to improve diagnostic accuracy such as pattern-based approaches to evaluation, mimickers of breast lesions arising in extra-mammary sites, and pitfalls specific to small tissue samples. In recent years, there have been several notable developments in the field of breast pathology including revisions in AJCC breast cancer staging, updated guidelines in the testing and reporting of ER, PR, and HER2, as well as implementation of immunotherapy and companion biomarker testing. In addition, several key updates were included in the most recent edition of the WHO Classification of Breast Tumours (2020). In addition to updates specific to individual breast entities, the second edition provides updates regarding biomarker testing in the primary and metastatic setting, and incorporates newly defined entities and updated definitions of rare tumors in alignment with the WHO Classification of Breast Tumours (2020). Furthermore, this edition addresses the role of CNB in companion biomarker testing for eligibility for immunotherapy in the context of advanced triple-negative breast carcinoma. Written by leaders in the field and edited by expert breast pathologists, The Second Edition of Comprehensive Guide to Core Needle Biopsies of the Breast is the definitive reference on breast core needle biopsies for practicing pathologists, pathology trainees, oncologists and clinicians of patients with breast disease. .
988			_aSpringer_Medicine_2022
650		7	_2embne _9667557 _aMamas _xCirugía
650		7	_2embne _9139108 _aBiopsia
700	1		_aShin, Sandra J _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aChen, Yunn-Yi _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aGinter, Paula S _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9783031055317
776	0	8	_iPrinted edition: _z9783031055331
776	0	8	_iPrinted edition: _z9783031055348
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-05532-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b01/2023 _dz _eu _zSI